Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This prospective randomized controlled study will be conducted to evaluate the analgesic
effect of continuous perineural infusion of methylene blue with bupivacaine on acute
postoperative pain and to evaluate its preventive role against chronic phantom pain in
patients undergoing lower limb amputation surgery